View ValuationeHealth 향후 성장Future 기준 점검 0/6eHealth 의 수익은 연간 5.7% 감소할 것으로 예상되는 반면, 연간 수익은 6.4% 로 증가할 것으로 예상됩니다. EPS는 연간 19.5% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 -1.5% 로 예상됩니다.핵심 정보6.4%이익 성장률19.46%EPS 성장률Insurance 이익 성장1.8%매출 성장률-5.7%향후 자기자본이익률-1.46%애널리스트 커버리지Low마지막 업데이트14 May 2026최근 향후 성장 업데이트Major Estimate Revision • Mar 04Consensus revenue estimates fall by 21%The consensus outlook for revenues in fiscal year 2026 has deteriorated. 2026 revenue forecast decreased from US$544.8m to US$428.3m. Forecast losses increased from -US$1.04 to -US$1.06 per share. Insurance industry in the US expected to see average net income growth of 7.5% next year. Consensus price target down from US$8.50 to US$3.75. Share price fell 10% to US$1.56 over the past week.Price Target Changed • Mar 01Price target decreased by 56% to US$3.75Down from US$8.50, the current price target is an average from 4 analysts. New target price is 188% above last closing price of US$1.30. Stock is down 85% over the past year. The company is forecast to post a net loss per share of US$1.06 next year compared to a net loss per share of US$0.34 last year.Major Estimate Revision • Dec 21Consensus EPS estimates upgraded to US$0.35 lossThe consensus outlook for fiscal year 2025 has been updated. 2025 losses forecast to reduce from -US$0.861 to -US$0.35 per share. Revenue forecast steady at US$546.0m. Insurance industry in the US expected to see average net income growth of 8.1% next year. Consensus price target of US$8.50 unchanged from last update. Share price fell 2.9% to US$4.37 over the past week.공시 • Dec 18eHealth, Inc. Revises Earnings Guidance for the Year Ending December 31, 2025eHealth, Inc. revised earnings guidance for the year ending December 31, 2025. For the year ending December 31, 2025, the company expects total revenue is expected to be in the range of $540.0 million to $560.0 million, compared to the prior range of $525.0 million to $565.0 million. GAAP net income is expected to be in the range of $30 million to $45 million, compared to the prior range of $9.0 million to $30.0 million.Price Target Changed • Nov 12Price target decreased by 7.9% to US$8.75Down from US$9.50, the current price target is an average from 4 analysts. New target price is 111% above last closing price of US$4.14. Stock is down 22% over the past year. The company is forecast to post a net loss per share of US$0.90 next year compared to a net loss per share of US$1.19 last year.Price Target Changed • Aug 26Price target decreased by 7.5% to US$9.25Down from US$10.00, the current price target is an average from 4 analysts. New target price is 141% above last closing price of US$3.84. Stock is down 5.4% over the past year. The company is forecast to post a net loss per share of US$0.84 next year compared to a net loss per share of US$1.19 last year.모든 업데이트 보기Recent updatesReported Earnings • May 08First quarter 2026 earnings: EPS and revenues exceed analyst expectationsFirst quarter 2026 results: US$0.58 loss per share (further deteriorated from US$0.33 loss in 1Q 2025). Revenue: US$88.0m (down 22% from 1Q 2025). Net loss: US$18.1m (loss widened 82% from 1Q 2025). Revenue exceeded analyst estimates by 8.3%. Earnings per share (EPS) also surpassed analyst estimates by 30%. Revenue is expected to decline by 5.6% p.a. on average during the next 3 years, while revenues in the Insurance industry in the US are expected to grow by 2.6%. Over the last 3 years on average, earnings per share has increased by 73% per year but the company’s share price has fallen by 37% per year, which means it is significantly lagging earnings.내러티브 업데이트 • May 06EHTH: Softer 2026 Revenue Guide And Benefit Launch Will Shape OutlookNarrative Update on eHealth Analysts have cut eHealth's average price target from about $5 to roughly $2, citing softer 2026 revenue expectations tied to reduced marketing spend by a major Medicare Advantage payor and cautious assumptions around the next annual enrollment period. Analyst Commentary Bearish analysts have moved quickly to reset expectations on eHealth, cutting price targets and shifting ratings to more neutral stances after the latest outlook.공시 • Apr 29eHealth, Inc., Annual General Meeting, Jun 18, 2026eHealth, Inc., Annual General Meeting, Jun 18, 2026.공시 • Apr 23eHealth, Inc. to Report Q1, 2026 Results on May 06, 2026eHealth, Inc. announced that they will report Q1, 2026 results on May 06, 2026내러티브 업데이트 • Apr 22EHTH: Margin Discipline And New Offerings Will Reframe Long Term ProspectsAnalysts have cut their price targets on eHealth significantly, with the consensus fair value moving from about $12.00 to roughly $3.00 as softer 2026 revenue guidance, reduced marketing spend from a major Medicare Advantage payor, and a tougher customer acquisition backdrop weigh on expectations. Analyst Commentary Recent Street research points to a more cautious stance on eHealth, with several firms cutting price targets and resetting expectations after the 2026 revenue guide.공시 • Apr 17eHealth Announces Final Expense Life Insurance PlanseHealth had announced it now offers Final Expense life insurance plans, helping Americans and their families prepare for funeral and burial or cremation expenses. The new plans are part of eHealth's strategy to better meet the coverage and wellness needs of individuals and families, offering an expanded portfolio of plans, services and support to help consumers live healthier, more financially secure lives. A new eHealth survey of over 1,000 Americans aged 65 and older found many people are unprepared to cover end-of-life expenses. Key survey findings include: 69% underestimate the average cost of a funeral with viewing and cremation, while 35% underestimate the average cost of a funeral with burial. 62% plan to be cremated, while 23% prefer to be buried; 15% don't know or have no preference. 47% worry about burdening loved ones with the cost of a funeral and burial or cremation. Among survey respondents living on an income of less than $50,000 per year: 56% worry about burdening their loved ones with the cost of a funeral and burial or cremation. 33% have no insurance or money set aside to help cover these end-of-life expenses. EHealth's Final Expense plans are offered through Mutual of Omaha and available by phone, allowing licensed insurance agents to address coverage options as part of a broader, personalized financial protection discussion. The policies can provide tax-free funds for various purposes, including funeral and burial or cremation expenses, outstanding medical bills, travel costs, legal fees, or other related needs. Two types of Final Expense plans are available: Level Benefit Plans, offered to people ages 45 to 85, with coverage amounts ranging from $2,000 to $50,000. Graded Benefit Plans, offered to people ages 45 to 80, with coverage amounts ranging from $2,000 to $20,000. Applicants are not required to undergo a medical exam to qualify for coverage. Instead, eligibility is determined through responses to a limited set of health questions covering a lookback period of approximately two to four years. The plans are designed to be affordable and provide beneficiaries with quick access to guaranteed funds, helping reduce financial stress during a difficult time. The average cost of a funeral with a viewing and burial exceeds $8,000, while the average cost of a funeral with a viewing and cremation is more than $6,000. Specific plan availability may vary by state; some plans may not be available in Arkansas, Montana, New York, and North Carolina. Coverage and premiums may vary based on qualifying factors.내러티브 업데이트 • Apr 07EHTH: Conservative 2026 Guide And Marketing Pullback Will Support Margin RepairAnalysts have cut the average price target on eHealth to about $2 to $3 per share, down sharply from prior targets near $8 to $9. They cite softer 2026 revenue guidance tied to reduced marketing spend by a key Medicare Advantage payor, conservative assumptions for the next annual enrollment period, and a planned pullback in some customer acquisition channels.공시 • Apr 01Andrea Brimmer to Step Down from Board of Directors of eHealth, Inc. on June 18, 2026eHealth, Inc. announced that Andrea Brimmer will not stand for re-election to the Company's Board of Directors and will step down when her current term expires at the Company's next annual meeting of shareholders to be held on June 18, 2026. Ms. Brimmer will continue to serve as a member of the Board until the expiration of her term at the Company's upcoming annual meeting.내러티브 업데이트 • Mar 24EHTH: Conservative 2026 Revenue Guide Will Support Margin Focused TurnaroundAnalysts have cut the average price target for eHealth by $1.50, citing softer than expected 2026 revenue guidance, reduced marketing spend by a major Medicare Advantage payor, and company plans to scale back certain customer acquisition channels while carriers remain focused on margins. Analyst Commentary Recent Street research reflects a more cautious stance on eHealth, with several firms cutting price targets and resetting expectations following the 2026 revenue guidance.내러티브 업데이트 • Mar 10EHTH: Higher 2025 Earnings Guidance Will Support Margin Focused TurnaroundAnalysts have sharply cut their average price target on eHealth from about $8.50 to roughly $3.75, reflecting lower $2 targets and a focus on weaker revenue expectations, along with an increased emphasis on margins and reduced customer acquisition spending. Analyst Commentary Recent research notes on eHealth highlight a meaningful reset in expectations, with price targets clustered around $2 and ratings largely at Hold.New Risk • Mar 04New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of American stocks, typically moving 15% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (15% average weekly change). Earnings are forecast to decline by an average of 9.5% per year for the foreseeable future. Minor Risks Currently unprofitable and not forecast to become profitable over next 3 years (US$6.6m net loss in 3 years). Market cap is less than US$100m (US$38.1m market cap).Major Estimate Revision • Mar 04Consensus revenue estimates fall by 21%The consensus outlook for revenues in fiscal year 2026 has deteriorated. 2026 revenue forecast decreased from US$544.8m to US$428.3m. Forecast losses increased from -US$1.04 to -US$1.06 per share. Insurance industry in the US expected to see average net income growth of 7.5% next year. Consensus price target down from US$8.50 to US$3.75. Share price fell 10% to US$1.56 over the past week.Recent Insider Transactions • Mar 03CEO & Director recently bought US$259k worth of stockOn the 27th of February, Derrick Duke bought around 188k shares on-market at roughly US$1.38 per share. This transaction amounted to 63% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Derrick's only on-market trade for the last 12 months.Price Target Changed • Mar 01Price target decreased by 56% to US$3.75Down from US$8.50, the current price target is an average from 4 analysts. New target price is 188% above last closing price of US$1.30. Stock is down 85% over the past year. The company is forecast to post a net loss per share of US$1.06 next year compared to a net loss per share of US$0.34 last year.New Risk • Feb 27New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 3.9% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 3.9% per year for the foreseeable future. Minor Risks Currently unprofitable and not forecast to become profitable over next 3 years (US$6.6m net loss in 3 years). Share price has been volatile over the past 3 months (15% average weekly change). Market cap is less than US$100m (US$40.9m market cap).Reported Earnings • Feb 26Full year 2025 earnings: EPS and revenues exceed analyst expectationsFull year 2025 results: US$0.34 loss per share (improved from US$1.19 loss in FY 2024). Revenue: US$554.0m (up 4.1% from FY 2024). Net loss: US$10.4m (loss narrowed 70% from FY 2024). Revenue exceeded analyst estimates by 1.5%. Earnings per share (EPS) also surpassed analyst estimates by 2.9%. Revenue is forecast to stay flat during the next 3 years compared to a 3.2% growth forecast for the Insurance industry in the US. Over the last 3 years on average, earnings per share has increased by 70% per year but the company’s share price has fallen by 46% per year, which means it is significantly lagging earnings.Valuation Update With 7 Day Price Move • Feb 25Investor sentiment improves as stock rises 22%After last week's 22% share price gain to US$1.89, the stock trades at a trailing P/E ratio of 43x. Average forward P/E is 10x in the Insurance industry in the US. Total loss to shareholders of 77% over the past three years.내러티브 업데이트 • Feb 24EHTH: Higher 2025 Earnings Guidance Will Support Future PerformanceAnalysts have modestly adjusted their price target on eHealth to reflect a slightly higher discount rate and a small change in the assumed future P/E multiple, while keeping fair value steady at $8.50 as they reassess risk and valuation inputs without new Street research catalysts. What's in the News eHealth updated its earnings guidance for the year ending December 31, 2025, with total revenue now expected in a range of $540.0 million to $560.0 million, compared with the prior range of $525.0 million to $565.0 million (Key Developments).Valuation Update With 7 Day Price Move • Feb 11Investor sentiment deteriorates as stock falls 25%After last week's 25% share price decline to US$1.98, the stock trades at a trailing P/E ratio of 45.1x. Average forward P/E is 10x in the Insurance industry in the US. Total loss to shareholders of 79% over the past three years.분석 기사 • Feb 10Market Cool On eHealth, Inc.'s (NASDAQ:EHTH) Revenues Pushing Shares 48% LowerThe eHealth, Inc. ( NASDAQ:EHTH ) share price has fared very poorly over the last month, falling by a substantial 48...공시 • Feb 10eHealth, Inc. to Report Q4, 2025 Results on Feb 25, 2026eHealth, Inc. announced that they will report Q4, 2025 results on Feb 25, 2026내러티브 업데이트 • Feb 09EHTH: Enrollment Strength And Softer Competition Will Support Future PerformanceAnalysts have trimmed their price target on eHealth to US$9 from US$10, citing price adjustments even as the annual enrollment period tracks in line with expectations, supported by solid consumer demand and early signs of a more favorable competitive backdrop. Analyst Commentary Bullish Takeaways Bullish analysts point to the annual enrollment period tracking in line with internal expectations, which they see as a sign that execution is holding up against current industry conditions.New Risk • Jan 28New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: US$93.5m This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (13% average weekly change). Market cap is less than US$100m (US$93.5m market cap).Valuation Update With 7 Day Price Move • Jan 27Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to US$3.04, the stock trades at a trailing P/E ratio of 69.2x. Average forward P/E is 10x in the Insurance industry in the US. Total loss to shareholders of 63% over the past three years.내러티브 업데이트 • Jan 26EHTH: Solid Enrollment Trends And Easing Competition Will Support Future MarginsAnalysts have trimmed their price target on eHealth to US$9 from US$10, citing annual enrollment trends that are tracking in line with expectations, along with signs of steady consumer demand and a somewhat more favorable competitive backdrop. Analyst Commentary Recent commentary around the price target cut frames eHealth as a company where execution looks generally on track, but with a valuation reset to reflect a more balanced risk and reward profile.내러티브 업데이트 • Jan 11EHTH: Solid Enrollment Trends And Healthier Competition Will Support Margin ExpansionAnalysts trimmed their price target on eHealth to US$9 from US$10, citing annual enrollment trends that are tracking in line with expectations, solid consumer demand on the platform, and early indications of a more favorable competitive environment. Analyst Commentary Analysts see a mixed picture for eHealth at the current US$9 price target, with solid execution on core drivers balanced against questions on how much upside is justified in the near term.내러티브 업데이트 • Dec 24EHTH: Strengthening Enrollment Trends Will Support Future Margin Expansion PotentialAnalysts have trimmed their price target on eHealth from $10.00 to $9.00 per share, citing in-line annual enrollment trends supported by strong platform demand and early signs of a more favorable competitive environment. Analyst Commentary Bullish Takeaways Bullish analysts highlight that the annual enrollment period is progressing in line with internal expectations, reinforcing confidence in management’s guidance and execution.Major Estimate Revision • Dec 21Consensus EPS estimates upgraded to US$0.35 lossThe consensus outlook for fiscal year 2025 has been updated. 2025 losses forecast to reduce from -US$0.861 to -US$0.35 per share. Revenue forecast steady at US$546.0m. Insurance industry in the US expected to see average net income growth of 8.1% next year. Consensus price target of US$8.50 unchanged from last update. Share price fell 2.9% to US$4.37 over the past week.분석 기사 • Dec 19Further Upside For eHealth, Inc. (NASDAQ:EHTH) Shares Could Introduce Price Risks After 35% BounceeHealth, Inc. ( NASDAQ:EHTH ) shareholders would be excited to see that the share price has had a great month, posting...공시 • Dec 18eHealth, Inc. Revises Earnings Guidance for the Year Ending December 31, 2025eHealth, Inc. revised earnings guidance for the year ending December 31, 2025. For the year ending December 31, 2025, the company expects total revenue is expected to be in the range of $540.0 million to $560.0 million, compared to the prior range of $525.0 million to $565.0 million. GAAP net income is expected to be in the range of $30 million to $45 million, compared to the prior range of $9.0 million to $30.0 million.내러티브 업데이트 • Dec 10EHTH: Improving Enrollment Dynamics Will Support Future Upside PotentialAnalysts have trimmed their price target on eHealth to $9 from $10, citing an annual enrollment period that is tracking in line with expectations, supported by solid consumer demand and a gradually improving competitive landscape. Analyst Commentary Analysts view the latest price target revision as a reflection of balanced expectations for eHealth, incorporating both the progress made in the current enrollment cycle and the lingering execution and competitive risks that could affect future growth and valuation.내러티브 업데이트 • Nov 26EHTH: Future Enrollment Trends Will Support Further Upside PotentialNarrative Update on eHealth: Analyst Price Target Revised Analysts have slightly reduced their price target for eHealth, lowering it from $8.75 to $8.50. This revision is due to a modest decrease in revenue growth outlook and a marginally higher discount rate.Valuation Update With 7 Day Price Move • Nov 20Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to US$3.32, the stock trades at a trailing P/E ratio of 75.5x. Average forward P/E is 10x in the Insurance industry in the US. Total returns to shareholders of 11% over the past three years.공시 • Nov 12eHealth Advances its AI Strategy with Expanded Voice Agent CapabilitieseHealth announced the expanded use of Alice, its AI-powered voice agent. Alice has expanded beyond its initial use for shopping and initial enrollment telephone support and is now assisting with post-enrollment and general service calls from Medicare Advantage beneficiaries, helping to efficiently address and resolve common inquiries such as: Application status: Alice provides customers with general information on their application status as provided by the health plan. Soon, she will also be able to look up specific details and inform callers exactly where their application is with the health plan in the process. ID card inquiries: Alice informs customers when they generally can expect to receive their insurance ID cards and, if necessary, directs them to contact their health plan for further assistance. Billing questions: Alice provides customers with direct billing contact phone numbers for their respective health plan, making it easier for individuals to access assistance when billing support is required. Do Not Call requests: Alice can initiate steps to remove customers from eHealth's call list upon request, ensuring their communication preferences are respected. eHealth's leadership in technology has defined the company since its founding. Today, eHealth has distinguished itself from other Medicare brokers by deploying leading AI technology at scale, continuing its commitment to improving the customer experience. The expansion of Alice marks another step forward in eHealth's mission to use technology to make healthcare simpler and more accessible for everyone. Alice already handles all after-hours Medicare Advantage inquiries and supports both initial enrollment assistance and service calls during business hours when agents are unavailable. In the future, eHealth plans to extend Alice's capabilities to assist individuals with shopping for other types of health insurance plans. For years, eHealth has leveraged AI and machine learning to match beneficiaries with the most suitable health plans based on their unique needs, including coverage requirements, physicians, and prescription drugs, from a broad catalog of leading national and regional insurers. To experience Alice in action, listen to this demo.내러티브 업데이트 • Nov 12EHTH: Future Profit Margins Will Drive Upside Despite Consumer ConfusionAnalysts have revised their price target for eHealth down from $9.25 to $8.75. They cite a significant reduction in projected profit margin, even though revenue growth forecasts have slightly improved and the estimated future price-to-earnings ratio is notably higher.Price Target Changed • Nov 12Price target decreased by 7.9% to US$8.75Down from US$9.50, the current price target is an average from 4 analysts. New target price is 111% above last closing price of US$4.14. Stock is down 22% over the past year. The company is forecast to post a net loss per share of US$0.90 next year compared to a net loss per share of US$1.19 last year.Seeking Alpha • Nov 08eHealth: Undervalued And Gaining Momentum After Q3 Earnings BeatSummary eHealth Inc. is positioned for a turnaround, leveraging digital platform enhancements, cost optimization, and strong insurer partnerships. EHTH trades at a deep discount to peers despite improved financials, nearly debt-free balance sheet, and superior liquidity and margins. Key risks include seasonality, regulatory changes, and competition, but Q3 earnings and open enrollment are positive signs of a turnaround. We rate EHTH a BUY, expecting a rebound to tangible book value ($14-$18/share) if FY25 guidance is met or exceeded. Read the full article on Seeking AlphaReported Earnings • Nov 06Third quarter 2025 earnings: EPS and revenues exceed analyst expectationsThird quarter 2025 results: US$1.46 loss per share (improved from US$1.83 loss in 3Q 2024). Revenue: US$53.9m (down 7.8% from 3Q 2024). Net loss: US$44.6m (loss narrowed 17% from 3Q 2024). Revenue exceeded analyst estimates by 3.4%. Earnings per share (EPS) also surpassed analyst estimates by 19%. Revenue is forecast to grow 4.6% p.a. on average during the next 3 years, compared to a 5.1% growth forecast for the Insurance industry in the US. Over the last 3 years on average, earnings per share has increased by 68% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings.공시 • Oct 31eHealth, Inc. to Report Q3, 2025 Results on Nov 05, 2025eHealth, Inc. announced that they will report Q3, 2025 results on Nov 05, 2025분석 기사 • Oct 28eHealth, Inc. (NASDAQ:EHTH) Held Back By Insufficient Growth Even After Shares Climb 34%Despite an already strong run, eHealth, Inc. ( NASDAQ:EHTH ) shares have been powering on, with a gain of 34% in the...공시 • Oct 01eHealth, Inc. Releases Findings from New SurveyeHealth, Inc. released findings from a new survey showing most Medicare beneficiaries find it confusing to shop for a plan during the Annual Enrollment Period (AEP), with about one-third of Medicare Advantage enrollees largely unaware of significant changes expected for the coming year. The survey of more than 1,500 Medicare beneficiaries offers timely insights as millions of Americans will soon make coverage decisions during this year's AEP, which runs from Oct. 15 through Dec. 7, 2025. Key findings from eHealth's survey include: 75% of Medicare beneficiaries said choosing a Medicare plan is confusing. 51% of Medicare beneficiaries intend to review their coverage options this AEP, compared to 63% who said they did so last year. 36% of Medicare Advantage and Part D plan enrollees said they are unaware that significant cost and benefit changes are expected for 2026. 33% of Medicare beneficiaries agree they don't have a good understanding of how Medicare Advantage, Medicare Supplement, and Part D plans differ. 33% of Medicare beneficiaries incorrectly believe Medicare covers GLP-1 drugs for weight loss. 29% of Medicare beneficiaries are unaware that Medicare covers recommended vaccines with no out-of-pocket costs.공시 • Sep 20eHealth, Inc Announces Board and Committee ChangesOn September 17, 2025, Aaron Tolson notified the Board of Directors of eHealth, Inc. he is resigning from the Board, as well as from the Board’s compensation committee, nominating and corporate governance committee and government and regulatory affairs committee, effective immediately. Mr. Tolson was initially appointed to the Board as a designee of Echelon Health SPV, LP pursuant to the terms of the Investment Agreement, dated February 17, 2021, by and between the Company and H.I.G. The resignation of Mr. Tolson was not the result of any disagreement between Mr. Tolson and the Company. On September 17, 2025, the Board appointed Todd Arden as a member of the Board, effective immediately. Mr. Arden was appointed to the Board as a designee of H.I.G. pursuant to the Investment Agreement and to fill the vacancy created by Mr. Tolson’s resignation. Mr. Arden will serve as a Class I director, with a term expiring at the Company’s 2028 annual meeting of stockholders. Mr. Arden was also appointed to the Board’s Compensation Committee, Nominating Committee and Government and Regulatory Affairs Committee. On September 18, 2025, the Board increased the number of directors of the Company from nine to ten and appointed Derrick Duke to serve as a Class I director of the Board, effective immediately, with a term expiring at the Company’s 2028 annual meeting of stockholders. No arrangement or understanding exists between Derrick Duke and any other person pursuant to which he was appointed as a director.분석 기사 • Sep 03eHealth, Inc. (NASDAQ:EHTH) Surges 26% Yet Its Low P/S Is No Reason For ExcitementThose holding eHealth, Inc. ( NASDAQ:EHTH ) shares would be relieved that the share price has rebounded 26% in the last...Price Target Changed • Aug 26Price target decreased by 7.5% to US$9.25Down from US$10.00, the current price target is an average from 4 analysts. New target price is 141% above last closing price of US$3.84. Stock is down 5.4% over the past year. The company is forecast to post a net loss per share of US$0.84 next year compared to a net loss per share of US$1.19 last year.분석 기사 • Aug 09The eHealth, Inc. (NASDAQ:EHTH) Second-Quarter Results Are Out And Analysts Have Published New ForecastsNasdaqGS:EHTH 1 Year Share Price vs Fair Value Explore eHealth's Fair Values from the Community and select yours...Price Target Changed • Aug 07Price target decreased by 11% to US$9.50Down from US$10.63, the current price target is an average from 4 analysts. New target price is 158% above last closing price of US$3.68. Stock is down 9.6% over the past year. The company is forecast to post a net loss per share of US$1.02 next year compared to a net loss per share of US$1.19 last year.Reported Earnings • Aug 06Second quarter 2025 earnings: EPS and revenues exceed analyst expectationsSecond quarter 2025 results: US$0.98 loss per share (improved from US$1.33 loss in 2Q 2024). Revenue: US$60.8m (down 7.7% from 2Q 2024). Net loss: US$29.8m (loss narrowed 24% from 2Q 2024). Revenue exceeded analyst estimates by 32%. Earnings per share (EPS) also surpassed analyst estimates by 33%. Revenue is forecast to grow 3.7% p.a. on average during the next 3 years, compared to a 5.4% growth forecast for the Insurance industry in the US. Over the last 3 years on average, earnings per share has increased by 62% per year but the company’s share price has fallen by 15% per year, which means it is significantly lagging earnings.New Risk • Aug 03New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: US$97.3m This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (US$17m net loss in 2 years). Share price has been volatile over the past 3 months (11% average weekly change). Market cap is less than US$100m (US$97.3m market cap).공시 • Jul 29eHealth, Inc. Announces CEO ChangeseHealth, Inc. announced that the Company's Board of Directors has appointed Derrick Duke as its next Chief Executive Officer. Duke will join eHealth on August 4, 2025, to begin the transition process before officially stepping into the CEO role and joining the Board of Directors on September 18th, 2025. He will succeed Fran Soistman, who, as previously announced, will retire from his role as CEO while continuing to serve on the Board. Soistman will remain with the Company as an executive advisor through December 31, 2025, to assist with the transition. Derrick Duke currently serves as CEO of Magellan Health, a leading national healthcare management organization and subsidiary of Centene Corporation. Previously, he held senior leadership roles at Magellan, including the dual roles of Chief Operating and Chief Financial Officer where he led the finance organization, business transformation initiatives, and behavioral health clinical services. Derrick Duke brings over 30 years of strategic leadership and financial expertise in the health insurance and managed care sectors. Most recently, he served as Chief Executive Officer at Magellan Health, a leading national healthcare management firm, where he led strategic growth and operational execution following a rapid rise through the C-suite – first as Chief Risk Officer in 2020, and then as Chief Operating and Financial Officer in early 2022.Before joining Magellan, Derrick spent nearly 16 years at Health Markets, one of the largest U.S. health insurance agencies, holding multiple senior roles including Chief Investment Officer, Chief Financial Officer, and Chief Operating Officer. He steered the company's finance, actuarial, IT, underwriting, compliance and customer service teams and helped lead the organization through its acquisition by UnitedHealth Group in 2019. Earlier in his career, Derrick was Executive Vice President and Chief Investment Officer at National Health Insurance (now part of Allstate Insurance), where he gained deep experience in investment strategy and insurer financial management. Derrick holds a bachelor's degree in finance from Hardin-Simmons University and an MBA from the University of Texas at Arlington.공시 • Jul 24eHealth, Inc. to Report Q2, 2025 Results on Aug 06, 2025eHealth, Inc. announced that they will report Q2, 2025 results on Aug 06, 2025분석 기사 • May 15eHealth, Inc.'s (NASDAQ:EHTH) 26% Dip In Price Shows Sentiment Is Matching RevenuesUnfortunately for some shareholders, the eHealth, Inc. ( NASDAQ:EHTH ) share price has dived 26% in the last thirty...Major Estimate Revision • May 14Consensus EPS estimates upgraded to US$1.27 lossThe consensus outlook for fiscal year 2025 has been updated. 2025 losses forecast to reduce from -US$1.56 to -US$1.27 per share. Revenue forecast steady at US$531.4m. Insurance industry in the US expected to see average net income growth of 12% next year. Consensus price target down from US$10.63 to US$10.00. Share price fell 21% to US$4.53 over the past week.New Risk • May 12New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of American stocks, typically moving 12% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (US$11m net loss in 2 years). Share price has been volatile over the past 3 months (12% average weekly change).Reported Earnings • May 08First quarter 2025 earnings: EPS and revenues exceed analyst expectationsFirst quarter 2025 results: EPS: US$0.077 (up from US$0.96 loss in 1Q 2024). Revenue: US$113.1m (up 22% from 1Q 2024). Net income: US$2.31m (up US$30.0m from 1Q 2024). Profit margin: 2.0% (up from net loss in 1Q 2024). The move to profitability was primarily driven by higher revenue. Revenue exceeded analyst estimates by 14%. Earnings per share (EPS) also surpassed analyst estimates. Revenue is forecast to grow 3.0% p.a. on average during the next 3 years, compared to a 5.1% growth forecast for the Insurance industry in the US. Over the last 3 years on average, earnings per share has increased by 53% per year but the company’s share price has fallen by 18% per year, which means it is significantly lagging earnings.공시 • Apr 30eHealth, Inc. Introduces AI Voice Agents to Enhance Customer Experience in Health Plan SelectioneHealth, Inc. unveiled a new AI-based voice, non-licensed agent designed to streamline the health insurance plan selection process. This launch marks a significant milestone in eHealth's ongoing, multi-year strategy to leverage AI empathetically, enhancing the expertise of licensed insurance agents to provide an exceptional consumer experience. The AI-based voice agents started by handling incoming Medicare calls to eHealth during after-hours, reducing the wait time for consumers who may otherwise need to wait longer to speak with a human screener. The AI-powered voice agents can enhance the customer experience by initiating the customer intake process, gathering personal information, checking initial eligibility, and communicating necessary disclosures. Since launching as a pilot earlier in 2025, among callers served by the AI agents, the program has: Eliminated after-hours wait times and ensured a 100% answer rate. Nearly doubled the percentage of callers (18.5% compared to 34.5%) who expressed interest in purchasing a plan, as compared to human screeners. The AI-based agents have expanded from initially handling after-hours calls to now assisting with incoming Medicare calls during business hours on a pilot basis. In the future, the AI agents are expected to serve people calling eHealth shopping for other types of insurance plans. In addition, a recent eHealth survey of over 500 consumers found significant interest in the use of AI to improve the experience when calling customer service. Among the findings from the survey regarding customer service in general: 74% are willing to answer a few questions from an AI assistant if it means getting faster and better help later in the process. 56% agree that working with an AI assistant can provide them with faster, more accurate help. 66% said long hold times are the biggest frustration when calling customer service, followed by difficulty reaching a real person (59%) and poorly trained agents (42%). Key features of the new eHealth AI-based voice agents: Streamlined information gathering. Using a conversational approach, the AI-based voice agents gather key details, including personal information, initial eligibility, and plan preferences. By streamlining the process, the AI agents can eliminate wait times and reduce the effort required for callers to shop for health benefits, making the plan selection process more accessible for everyone. Enhanced accuracy and cost efficiency. Using advanced algorithms and voice-recognition technology, the AI agents help minimize errors and ensure callers are matched with an appropriate licensed insurance agent to then review appropriate plan options based on location, health care goals and budget. Compared to human screeners, the AI agents are more cost efficient. User-friendly and consistent service: The intuitive experience of the AI-based voice agents enables users to provide initial information more easily and start the plan selection experience, while expediting the process once the caller is connected to a live, licensed insurance agent. The AI agents are designed to answer all customer questions with empathy and patience, with feedback from callers emphasizing feelings of being respected and valued.공시 • Apr 29eHealth, Inc., Annual General Meeting, Jun 18, 2025eHealth, Inc., Annual General Meeting, Jun 18, 2025.공시 • Apr 24eHealth, Inc. to Report Q1, 2025 Results on May 07, 2025eHealth, Inc. announced that they will report Q1, 2025 results at 12:30 PM, US Eastern Standard Time on May 07, 2025새로운 내러티브 • Mar 31Medicare Focus And AI Projects Will Improve Operations Revenue and earnings growth driven by increased Medicare submissions, marketing investments, and enhanced enrollment margins. 분석 기사 • Mar 16Benign Growth For eHealth, Inc. (NASDAQ:EHTH) Underpins Stock's 30% PlummetThe eHealth, Inc. ( NASDAQ:EHTH ) share price has softened a substantial 30% over the previous 30 days, handing back...Major Estimate Revision • Mar 06Consensus EPS estimates fall by 39%The consensus outlook for fiscal year 2025 has been updated. 2025 expected loss increased from -US$1.12 to -US$1.56 per share. Revenue forecast unchanged at US$529.8m. Insurance industry in the US expected to see average net income growth of 8.4% next year. Consensus price target up from US$8.63 to US$10.63. Share price fell 6.7% to US$8.29 over the past week.Breakeven Date Change • Mar 02No longer forecast to breakevenThe 5 analysts covering eHealth no longer expect the company to break even during the foreseeable future. The company was expected to make a profit of US$2.28m in 2026. New consensus forecast suggests the company will make a loss of US$16.6m in 2026.공시 • Mar 01Ehealth, Inc. Provides Earnings Guidance for the Full Year Ending December 31, 2025eHealth, Inc. provided earnings guidance for the full year ending December 31, 2025. For the year, the company expects Total revenue is expected to be in the range of $510.0 million to $550.0 million. GAAP net income (loss) is expected to be in the range of $(10.0) million to $15.0 million.Reported Earnings • Feb 26Full year 2024 earnings: EPS and revenues exceed analyst expectationsFull year 2024 results: US$1.19 loss per share (improved from US$2.37 loss in FY 2023). Revenue: US$532.4m (up 18% from FY 2023). Net loss: US$35.0m (loss narrowed 47% from FY 2023). Revenue exceeded analyst estimates by 4.3%. Earnings per share (EPS) also surpassed analyst estimates by 15%. Revenue is forecast to grow 4.0% p.a. on average during the next 2 years, compared to a 5.2% growth forecast for the Insurance industry in the US. Over the last 3 years on average, earnings per share has increased by 40% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings.Seeking Alpha • Feb 26eHealth: Another Big Run, Lock In, And Run House MoneySummary eHealth, Inc. was recommended at $6.78; now, with current gains to above $9, we suggest you lock in profits and hold EHTH stock for long-term growth. eHealth showed strong Q4 performance, but it was an outlier. We like EHTH shares for long-term exposure, but 2025 at best looks flat from 2024. Consider a house position after the rapid-return trade. Read the full article on Seeking Alpha공시 • Feb 13eHealth, Inc. to Report Q4, 2024 Results on Feb 26, 2025eHealth, Inc. announced that they will report Q4, 2024 results on Feb 26, 2025공시 • Jan 29"Iris by eHealth" ICHRA Solution Makes Employer Health Benefits Affordable with Personalized Coverage for EmployeeseHealth, Inc. announced the launch of Iris by eHealth, an end-to-end Individual Coverage Health Reimbursement Account (ICHRA) solution for employers who want to support employee healthcare but struggle with the unpredictable costs of group health plans. Here's how Iris by eHealth works: The employer determines a flat monthly contribution to be made toward each employee's health coverage, Using eHealth's Iris platform, employees select their own plan from among top insurance companies in their area, By adding their preferred doctors and prescriptions, they can narrow down their choices to those best suited to their personal needs, eHealth's proven customer care team manages enrollments and provides direct support to employees, Once enrolled, the employer's monthly contribution funds some, or all, of the employee's health insurance premiums. There are no plan markups or hidden fees with Iris. eHealth's licensed agents are available nationwide by phone or chat to help employers and their employees find the coverage they need, with a free annual review of plan options.Major Estimate Revision • Jan 12Consensus EPS estimates fall by 23%, revenue upgradedThe consensus outlook for fiscal year 2024 has been updated. 2024 revenue forecast increased from US$498.0m to US$504.0m. Forecast EPS reduced from -US$1.14 to -US$1.40 per share. Insurance industry in the US expected to see average net income growth of 13% next year. Consensus price target up from US$7.38 to US$8.63. Share price rose 3.1% to US$9.85 over the past week.Breakeven Date Change • Dec 31Forecast to breakeven in 2026The 5 analysts covering eHealth expect the company to break even for the first time. New consensus forecast suggests losses will reduce by 25% per year to 2025. The company is expected to make a profit of US$2.28m in 2026. Average annual earnings growth of 79% is required to achieve expected profit on schedule.분석 기사 • Dec 23Market Might Still Lack Some Conviction On eHealth, Inc. (NASDAQ:EHTH) Even After 66% Share Price BoosteHealth, Inc. ( NASDAQ:EHTH ) shares have continued their recent momentum with a 66% gain in the last month alone. Not...Price Target Changed • Dec 19Price target increased by 11% to US$7.38Up from US$6.63, the current price target is an average from 4 analysts. New target price is 11% below last closing price of US$8.28. Stock is down 7.7% over the past year. The company is forecast to post a net loss per share of US$1.50 next year compared to a net loss per share of US$2.37 last year.공시 • Dec 18eHealth, Inc. Revises Earnings Guidance for the Full Year Ending December 31, 2024eHealth, Inc. revised earnings guidance for the full year ending December 31, 2024. Total revenue is expected to be in the range of $500.0 million to $520.0 million compared to the prior range of $470.0 million to $495.0 million. GAAP net income (loss) is expected to be in the range of $(12.0) million to $3.0 million compared to the prior range of $(36.5) million to $(22.0) million.New Risk • Dec 17New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of American stocks, typically moving 14% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (US$13m net loss in 2 years). Share price has been volatile over the past 3 months (14% average weekly change). Shareholders have been diluted in the past year (4.5% increase in shares outstanding). Significant insider selling over the past 3 months (US$105k sold).Seeking Alpha • Dec 17Bull Run For EHealth, Inc.: Stock Flying On Solid EnrollmentSummary eHealth, Inc. is an online health insurance marketplace with strong enrollment, particularly in Medicare plans, aided by new technologies and live assistance. Despite a 90%+ drop from its 2020 peak, Q3 2024 showed signs of improvement, with a 16% decline in acquisition costs and a 6% reduction in adjusted net loss. Significant growth in submitted Medicare applications and a new member retention program have led to raised revenue and profit guidance for 2024. EHTH stock, is likely heading to double digits in 2025, driven by improved outlook and retention strategies. Read the full article on Seeking AlphaBoard Change • Dec 01Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 8 experienced directors. No highly experienced directors. Independent Director Prama Bhatt was the last director to join the board, commencing their role in 2024. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Price Target Changed • Nov 26Price target decreased by 8.7% to US$7.00Down from US$7.67, the current price target is an average from 3 analysts. New target price is 30% above last closing price of US$5.37. Stock is down 28% over the past year. The company is forecast to post a net loss per share of US$1.54 next year compared to a net loss per share of US$2.37 last year.Recent Insider Transactions • Nov 15Independent Director recently sold US$105k worth of stockOn the 11th of November, Dale Wolf sold around 20k shares on-market at roughly US$5.25 per share. This transaction amounted to 14% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Despite this recent sale, insiders have collectively bought US$253k more than they sold in the last 12 months.Recent Insider Transactions Derivative • Nov 11Independent Director notifies of intention to sell stockDale Wolf intends to sell 20k shares in the next 90 days after lodging an Intent To Sell Form on the 8th of November. If the sale is conducted around the recent share price of US$5.43, it would amount to US$109k. Since June 2024, Dale has owned 139.73k shares directly. Company insiders have collectively bought US$358k more than they sold, via options and on-market transactions, in the last 12 months.분석 기사 • Nov 08A Piece Of The Puzzle Missing From eHealth, Inc.'s (NASDAQ:EHTH) 31% Share Price ClimbThe eHealth, Inc. ( NASDAQ:EHTH ) share price has done very well over the last month, posting an excellent gain of 31...Reported Earnings • Nov 07Third quarter 2024 earnings: EPS misses analyst expectationsThird quarter 2024 results: US$1.83 loss per share (further deteriorated from US$1.68 loss in 3Q 2023). Revenue: US$58.4m (down 9.7% from 3Q 2023). Net loss: US$53.9m (loss widened 14% from 3Q 2023). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 20%. Revenue is forecast to grow 8.3% p.a. on average during the next 3 years, compared to a 5.2% growth forecast for the Insurance industry in the US. Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has fallen by 43% per year, which means it is significantly lagging earnings.공시 • Oct 23eHealth, Inc. to Report Q3, 2024 Results on Nov 06, 2024eHealth, Inc. announced that they will report Q3, 2024 results on Nov 06, 2024Board Change • Sep 01Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 7 experienced directors. No highly experienced directors. CEO & Director Fran Soistman was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.분석 기사 • Aug 30Positive Sentiment Still Eludes eHealth, Inc. (NASDAQ:EHTH) Following 25% Share Price SlumpTo the annoyance of some shareholders, eHealth, Inc. ( NASDAQ:EHTH ) shares are down a considerable 25% in the last...Price Target Changed • Aug 14Price target decreased by 17% to US$6.67Down from US$8.00, the current price target is an average from 3 analysts. New target price is 65% above last closing price of US$4.04. Stock is down 52% over the past year. The company is forecast to post a net loss per share of US$1.52 next year compared to a net loss per share of US$2.37 last year.Major Estimate Revision • Aug 14Consensus EPS estimates fall by 99%, revenue upgradedThe consensus outlook for fiscal year 2024 has been updated. 2024 revenue forecast increased from US$468.5m to US$481.6m. Forecast EPS reduced from -US$0.76 to -US$1.52 per share. Insurance industry in the US expected to see average net income growth of 16% next year. Consensus price target down from US$8.00 to US$6.67. Share price rose 5.5% to US$4.04 over the past week.New Risk • Aug 11New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of American stocks, typically moving 10.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (US$15m net loss in 2 years). Share price has been volatile over the past 3 months (10.0% average weekly change). Shareholders have been diluted in the past year (4.7% increase in shares outstanding).Price Target Changed • Aug 08Price target decreased by 8.0% to US$7.67Down from US$8.33, the current price target is an average from 3 analysts. New target price is 88% above last closing price of US$4.07. Stock is down 54% over the past year. The company is forecast to post a net loss per share of US$0.88 next year compared to a net loss per share of US$2.37 last year.공시 • Aug 07eHealth, Inc. Announces Retirement of Fran Soistman as Chief Executive OfficereHealth, Inc. announced that Fran Soistman will retire from his role as Chief Executive Officer upon the appointment of a successor, which is expected to occur by or before the second quarter of 2025. Following his retirement as CEO, Mr. Soistman intends to remain a director on the Company's Board of Directors. Mr. Soistman will support the new CEO to ensure a seamless transition. The Board has commenced a search for Mr. Soistman's successor and has engaged Spencer Stuart, to identify and evaluate both internal and external candidates.공시 • Jul 23eHealth, Inc. to Report Q2, 2024 Results on Aug 07, 2024eHealth, Inc. announced that they will report Q2, 2024 results on Aug 07, 2024공시 • Jul 03+ 4 more updateseHealth, Inc.(NasdaqGS:EHTH) dropped from Russell 3000 IndexeHealth, Inc.(NasdaqGS:EHTH) dropped from Russell 3000 Index이익 및 매출 성장 예측NasdaqGS:EHTH - 애널리스트 향후 추정치 및 과거 재무 데이터 (USD Millions)날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수12/31/2028485-5N/AN/A112/31/2027447-284029512/31/2026429-34331953/31/2026529-19-81-67N/A12/31/2025554-10-41-25N/A9/30/20255431-33-17N/A6/30/2025547-8-38-21N/A3/31/2025553-17-26-12N/A12/31/2024532-35-31-18N/A9/30/2024465-79-36-24N/A6/30/2024471-72-31-19N/A3/31/2024472-66-83N/A12/31/2023453-67-17-7N/A9/30/2023402-96-38N/A6/30/2023390-95-83N/A3/31/2023374-108-27-13N/A12/31/2022405-119-42-27N/A9/30/2022453-171-128-111N/A6/30/2022463-184-171-152N/A3/31/2022509-162-178-158N/A12/31/2021538-123-183-163N/A9/30/2021588-24-179-157N/A6/30/202161822-106-85N/A3/31/202161141-97-74N/A12/31/202058345-132-108N/A9/30/202059174-91-68N/A6/30/202056778-107-85N/A3/31/202054475-95-75N/A12/31/201950667N/A-71N/A9/30/20193394N/A-23N/A6/30/20193106N/A-12N/A3/31/20192770N/A-1N/A12/31/20182510N/A-3N/A9/30/20182002N/A-5N/A6/30/20181909N/A-13N/A3/31/201819220N/A-13N/A12/31/201719125N/A-16N/A9/30/2017151-19N/A-10N/A6/30/2017152-23N/A4N/A3/31/2017155-22N/A8N/A12/31/20161930N/A4N/A9/30/20161930N/A10N/A6/30/20161999N/A19N/A3/31/201620215N/A30N/A12/31/2015190-5N/A14N/A9/30/2015184-12N/A8N/A6/30/2015187-14N/A8N/A더 보기애널리스트 향후 성장 전망수입 대 저축률: EHTH 향후 3년 동안 수익성이 없을 것으로 예상됩니다.수익 vs 시장: EHTH 향후 3년 동안 수익성이 없을 것으로 예상됩니다.고성장 수익: EHTH 향후 3년 동안 수익성이 없을 것으로 예상됩니다.수익 대 시장: EHTH 의 수익은 향후 3년간 감소할 것으로 예상됩니다(연간 -5.7%).고성장 매출: EHTH 의 수익은 향후 3년 동안 감소할 것으로 예상됩니다(연간 -5.7%).주당순이익 성장 예측향후 자기자본이익률미래 ROE: EHTH는 3년 뒤에도 수익성이 없을 것으로 전망됩니다.성장 기업 찾아보기7D1Y7D1Y7D1YInsurance 산업의 고성장 기업.View Past Performance기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/17 04:38종가2026/05/15 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스eHealth, Inc.는 25명의 분석가가 다루고 있습니다. 이 중 5명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Steven ValiquetteBarclaysSteven ValiquetteBarclaysNathaniel SchindlerBofA Global Research22명의 분석가 더 보기
Major Estimate Revision • Mar 04Consensus revenue estimates fall by 21%The consensus outlook for revenues in fiscal year 2026 has deteriorated. 2026 revenue forecast decreased from US$544.8m to US$428.3m. Forecast losses increased from -US$1.04 to -US$1.06 per share. Insurance industry in the US expected to see average net income growth of 7.5% next year. Consensus price target down from US$8.50 to US$3.75. Share price fell 10% to US$1.56 over the past week.
Price Target Changed • Mar 01Price target decreased by 56% to US$3.75Down from US$8.50, the current price target is an average from 4 analysts. New target price is 188% above last closing price of US$1.30. Stock is down 85% over the past year. The company is forecast to post a net loss per share of US$1.06 next year compared to a net loss per share of US$0.34 last year.
Major Estimate Revision • Dec 21Consensus EPS estimates upgraded to US$0.35 lossThe consensus outlook for fiscal year 2025 has been updated. 2025 losses forecast to reduce from -US$0.861 to -US$0.35 per share. Revenue forecast steady at US$546.0m. Insurance industry in the US expected to see average net income growth of 8.1% next year. Consensus price target of US$8.50 unchanged from last update. Share price fell 2.9% to US$4.37 over the past week.
공시 • Dec 18eHealth, Inc. Revises Earnings Guidance for the Year Ending December 31, 2025eHealth, Inc. revised earnings guidance for the year ending December 31, 2025. For the year ending December 31, 2025, the company expects total revenue is expected to be in the range of $540.0 million to $560.0 million, compared to the prior range of $525.0 million to $565.0 million. GAAP net income is expected to be in the range of $30 million to $45 million, compared to the prior range of $9.0 million to $30.0 million.
Price Target Changed • Nov 12Price target decreased by 7.9% to US$8.75Down from US$9.50, the current price target is an average from 4 analysts. New target price is 111% above last closing price of US$4.14. Stock is down 22% over the past year. The company is forecast to post a net loss per share of US$0.90 next year compared to a net loss per share of US$1.19 last year.
Price Target Changed • Aug 26Price target decreased by 7.5% to US$9.25Down from US$10.00, the current price target is an average from 4 analysts. New target price is 141% above last closing price of US$3.84. Stock is down 5.4% over the past year. The company is forecast to post a net loss per share of US$0.84 next year compared to a net loss per share of US$1.19 last year.
Reported Earnings • May 08First quarter 2026 earnings: EPS and revenues exceed analyst expectationsFirst quarter 2026 results: US$0.58 loss per share (further deteriorated from US$0.33 loss in 1Q 2025). Revenue: US$88.0m (down 22% from 1Q 2025). Net loss: US$18.1m (loss widened 82% from 1Q 2025). Revenue exceeded analyst estimates by 8.3%. Earnings per share (EPS) also surpassed analyst estimates by 30%. Revenue is expected to decline by 5.6% p.a. on average during the next 3 years, while revenues in the Insurance industry in the US are expected to grow by 2.6%. Over the last 3 years on average, earnings per share has increased by 73% per year but the company’s share price has fallen by 37% per year, which means it is significantly lagging earnings.
내러티브 업데이트 • May 06EHTH: Softer 2026 Revenue Guide And Benefit Launch Will Shape OutlookNarrative Update on eHealth Analysts have cut eHealth's average price target from about $5 to roughly $2, citing softer 2026 revenue expectations tied to reduced marketing spend by a major Medicare Advantage payor and cautious assumptions around the next annual enrollment period. Analyst Commentary Bearish analysts have moved quickly to reset expectations on eHealth, cutting price targets and shifting ratings to more neutral stances after the latest outlook.
공시 • Apr 29eHealth, Inc., Annual General Meeting, Jun 18, 2026eHealth, Inc., Annual General Meeting, Jun 18, 2026.
공시 • Apr 23eHealth, Inc. to Report Q1, 2026 Results on May 06, 2026eHealth, Inc. announced that they will report Q1, 2026 results on May 06, 2026
내러티브 업데이트 • Apr 22EHTH: Margin Discipline And New Offerings Will Reframe Long Term ProspectsAnalysts have cut their price targets on eHealth significantly, with the consensus fair value moving from about $12.00 to roughly $3.00 as softer 2026 revenue guidance, reduced marketing spend from a major Medicare Advantage payor, and a tougher customer acquisition backdrop weigh on expectations. Analyst Commentary Recent Street research points to a more cautious stance on eHealth, with several firms cutting price targets and resetting expectations after the 2026 revenue guide.
공시 • Apr 17eHealth Announces Final Expense Life Insurance PlanseHealth had announced it now offers Final Expense life insurance plans, helping Americans and their families prepare for funeral and burial or cremation expenses. The new plans are part of eHealth's strategy to better meet the coverage and wellness needs of individuals and families, offering an expanded portfolio of plans, services and support to help consumers live healthier, more financially secure lives. A new eHealth survey of over 1,000 Americans aged 65 and older found many people are unprepared to cover end-of-life expenses. Key survey findings include: 69% underestimate the average cost of a funeral with viewing and cremation, while 35% underestimate the average cost of a funeral with burial. 62% plan to be cremated, while 23% prefer to be buried; 15% don't know or have no preference. 47% worry about burdening loved ones with the cost of a funeral and burial or cremation. Among survey respondents living on an income of less than $50,000 per year: 56% worry about burdening their loved ones with the cost of a funeral and burial or cremation. 33% have no insurance or money set aside to help cover these end-of-life expenses. EHealth's Final Expense plans are offered through Mutual of Omaha and available by phone, allowing licensed insurance agents to address coverage options as part of a broader, personalized financial protection discussion. The policies can provide tax-free funds for various purposes, including funeral and burial or cremation expenses, outstanding medical bills, travel costs, legal fees, or other related needs. Two types of Final Expense plans are available: Level Benefit Plans, offered to people ages 45 to 85, with coverage amounts ranging from $2,000 to $50,000. Graded Benefit Plans, offered to people ages 45 to 80, with coverage amounts ranging from $2,000 to $20,000. Applicants are not required to undergo a medical exam to qualify for coverage. Instead, eligibility is determined through responses to a limited set of health questions covering a lookback period of approximately two to four years. The plans are designed to be affordable and provide beneficiaries with quick access to guaranteed funds, helping reduce financial stress during a difficult time. The average cost of a funeral with a viewing and burial exceeds $8,000, while the average cost of a funeral with a viewing and cremation is more than $6,000. Specific plan availability may vary by state; some plans may not be available in Arkansas, Montana, New York, and North Carolina. Coverage and premiums may vary based on qualifying factors.
내러티브 업데이트 • Apr 07EHTH: Conservative 2026 Guide And Marketing Pullback Will Support Margin RepairAnalysts have cut the average price target on eHealth to about $2 to $3 per share, down sharply from prior targets near $8 to $9. They cite softer 2026 revenue guidance tied to reduced marketing spend by a key Medicare Advantage payor, conservative assumptions for the next annual enrollment period, and a planned pullback in some customer acquisition channels.
공시 • Apr 01Andrea Brimmer to Step Down from Board of Directors of eHealth, Inc. on June 18, 2026eHealth, Inc. announced that Andrea Brimmer will not stand for re-election to the Company's Board of Directors and will step down when her current term expires at the Company's next annual meeting of shareholders to be held on June 18, 2026. Ms. Brimmer will continue to serve as a member of the Board until the expiration of her term at the Company's upcoming annual meeting.
내러티브 업데이트 • Mar 24EHTH: Conservative 2026 Revenue Guide Will Support Margin Focused TurnaroundAnalysts have cut the average price target for eHealth by $1.50, citing softer than expected 2026 revenue guidance, reduced marketing spend by a major Medicare Advantage payor, and company plans to scale back certain customer acquisition channels while carriers remain focused on margins. Analyst Commentary Recent Street research reflects a more cautious stance on eHealth, with several firms cutting price targets and resetting expectations following the 2026 revenue guidance.
내러티브 업데이트 • Mar 10EHTH: Higher 2025 Earnings Guidance Will Support Margin Focused TurnaroundAnalysts have sharply cut their average price target on eHealth from about $8.50 to roughly $3.75, reflecting lower $2 targets and a focus on weaker revenue expectations, along with an increased emphasis on margins and reduced customer acquisition spending. Analyst Commentary Recent research notes on eHealth highlight a meaningful reset in expectations, with price targets clustered around $2 and ratings largely at Hold.
New Risk • Mar 04New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of American stocks, typically moving 15% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (15% average weekly change). Earnings are forecast to decline by an average of 9.5% per year for the foreseeable future. Minor Risks Currently unprofitable and not forecast to become profitable over next 3 years (US$6.6m net loss in 3 years). Market cap is less than US$100m (US$38.1m market cap).
Major Estimate Revision • Mar 04Consensus revenue estimates fall by 21%The consensus outlook for revenues in fiscal year 2026 has deteriorated. 2026 revenue forecast decreased from US$544.8m to US$428.3m. Forecast losses increased from -US$1.04 to -US$1.06 per share. Insurance industry in the US expected to see average net income growth of 7.5% next year. Consensus price target down from US$8.50 to US$3.75. Share price fell 10% to US$1.56 over the past week.
Recent Insider Transactions • Mar 03CEO & Director recently bought US$259k worth of stockOn the 27th of February, Derrick Duke bought around 188k shares on-market at roughly US$1.38 per share. This transaction amounted to 63% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Derrick's only on-market trade for the last 12 months.
Price Target Changed • Mar 01Price target decreased by 56% to US$3.75Down from US$8.50, the current price target is an average from 4 analysts. New target price is 188% above last closing price of US$1.30. Stock is down 85% over the past year. The company is forecast to post a net loss per share of US$1.06 next year compared to a net loss per share of US$0.34 last year.
New Risk • Feb 27New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 3.9% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 3.9% per year for the foreseeable future. Minor Risks Currently unprofitable and not forecast to become profitable over next 3 years (US$6.6m net loss in 3 years). Share price has been volatile over the past 3 months (15% average weekly change). Market cap is less than US$100m (US$40.9m market cap).
Reported Earnings • Feb 26Full year 2025 earnings: EPS and revenues exceed analyst expectationsFull year 2025 results: US$0.34 loss per share (improved from US$1.19 loss in FY 2024). Revenue: US$554.0m (up 4.1% from FY 2024). Net loss: US$10.4m (loss narrowed 70% from FY 2024). Revenue exceeded analyst estimates by 1.5%. Earnings per share (EPS) also surpassed analyst estimates by 2.9%. Revenue is forecast to stay flat during the next 3 years compared to a 3.2% growth forecast for the Insurance industry in the US. Over the last 3 years on average, earnings per share has increased by 70% per year but the company’s share price has fallen by 46% per year, which means it is significantly lagging earnings.
Valuation Update With 7 Day Price Move • Feb 25Investor sentiment improves as stock rises 22%After last week's 22% share price gain to US$1.89, the stock trades at a trailing P/E ratio of 43x. Average forward P/E is 10x in the Insurance industry in the US. Total loss to shareholders of 77% over the past three years.
내러티브 업데이트 • Feb 24EHTH: Higher 2025 Earnings Guidance Will Support Future PerformanceAnalysts have modestly adjusted their price target on eHealth to reflect a slightly higher discount rate and a small change in the assumed future P/E multiple, while keeping fair value steady at $8.50 as they reassess risk and valuation inputs without new Street research catalysts. What's in the News eHealth updated its earnings guidance for the year ending December 31, 2025, with total revenue now expected in a range of $540.0 million to $560.0 million, compared with the prior range of $525.0 million to $565.0 million (Key Developments).
Valuation Update With 7 Day Price Move • Feb 11Investor sentiment deteriorates as stock falls 25%After last week's 25% share price decline to US$1.98, the stock trades at a trailing P/E ratio of 45.1x. Average forward P/E is 10x in the Insurance industry in the US. Total loss to shareholders of 79% over the past three years.
분석 기사 • Feb 10Market Cool On eHealth, Inc.'s (NASDAQ:EHTH) Revenues Pushing Shares 48% LowerThe eHealth, Inc. ( NASDAQ:EHTH ) share price has fared very poorly over the last month, falling by a substantial 48...
공시 • Feb 10eHealth, Inc. to Report Q4, 2025 Results on Feb 25, 2026eHealth, Inc. announced that they will report Q4, 2025 results on Feb 25, 2026
내러티브 업데이트 • Feb 09EHTH: Enrollment Strength And Softer Competition Will Support Future PerformanceAnalysts have trimmed their price target on eHealth to US$9 from US$10, citing price adjustments even as the annual enrollment period tracks in line with expectations, supported by solid consumer demand and early signs of a more favorable competitive backdrop. Analyst Commentary Bullish Takeaways Bullish analysts point to the annual enrollment period tracking in line with internal expectations, which they see as a sign that execution is holding up against current industry conditions.
New Risk • Jan 28New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: US$93.5m This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (13% average weekly change). Market cap is less than US$100m (US$93.5m market cap).
Valuation Update With 7 Day Price Move • Jan 27Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to US$3.04, the stock trades at a trailing P/E ratio of 69.2x. Average forward P/E is 10x in the Insurance industry in the US. Total loss to shareholders of 63% over the past three years.
내러티브 업데이트 • Jan 26EHTH: Solid Enrollment Trends And Easing Competition Will Support Future MarginsAnalysts have trimmed their price target on eHealth to US$9 from US$10, citing annual enrollment trends that are tracking in line with expectations, along with signs of steady consumer demand and a somewhat more favorable competitive backdrop. Analyst Commentary Recent commentary around the price target cut frames eHealth as a company where execution looks generally on track, but with a valuation reset to reflect a more balanced risk and reward profile.
내러티브 업데이트 • Jan 11EHTH: Solid Enrollment Trends And Healthier Competition Will Support Margin ExpansionAnalysts trimmed their price target on eHealth to US$9 from US$10, citing annual enrollment trends that are tracking in line with expectations, solid consumer demand on the platform, and early indications of a more favorable competitive environment. Analyst Commentary Analysts see a mixed picture for eHealth at the current US$9 price target, with solid execution on core drivers balanced against questions on how much upside is justified in the near term.
내러티브 업데이트 • Dec 24EHTH: Strengthening Enrollment Trends Will Support Future Margin Expansion PotentialAnalysts have trimmed their price target on eHealth from $10.00 to $9.00 per share, citing in-line annual enrollment trends supported by strong platform demand and early signs of a more favorable competitive environment. Analyst Commentary Bullish Takeaways Bullish analysts highlight that the annual enrollment period is progressing in line with internal expectations, reinforcing confidence in management’s guidance and execution.
Major Estimate Revision • Dec 21Consensus EPS estimates upgraded to US$0.35 lossThe consensus outlook for fiscal year 2025 has been updated. 2025 losses forecast to reduce from -US$0.861 to -US$0.35 per share. Revenue forecast steady at US$546.0m. Insurance industry in the US expected to see average net income growth of 8.1% next year. Consensus price target of US$8.50 unchanged from last update. Share price fell 2.9% to US$4.37 over the past week.
분석 기사 • Dec 19Further Upside For eHealth, Inc. (NASDAQ:EHTH) Shares Could Introduce Price Risks After 35% BounceeHealth, Inc. ( NASDAQ:EHTH ) shareholders would be excited to see that the share price has had a great month, posting...
공시 • Dec 18eHealth, Inc. Revises Earnings Guidance for the Year Ending December 31, 2025eHealth, Inc. revised earnings guidance for the year ending December 31, 2025. For the year ending December 31, 2025, the company expects total revenue is expected to be in the range of $540.0 million to $560.0 million, compared to the prior range of $525.0 million to $565.0 million. GAAP net income is expected to be in the range of $30 million to $45 million, compared to the prior range of $9.0 million to $30.0 million.
내러티브 업데이트 • Dec 10EHTH: Improving Enrollment Dynamics Will Support Future Upside PotentialAnalysts have trimmed their price target on eHealth to $9 from $10, citing an annual enrollment period that is tracking in line with expectations, supported by solid consumer demand and a gradually improving competitive landscape. Analyst Commentary Analysts view the latest price target revision as a reflection of balanced expectations for eHealth, incorporating both the progress made in the current enrollment cycle and the lingering execution and competitive risks that could affect future growth and valuation.
내러티브 업데이트 • Nov 26EHTH: Future Enrollment Trends Will Support Further Upside PotentialNarrative Update on eHealth: Analyst Price Target Revised Analysts have slightly reduced their price target for eHealth, lowering it from $8.75 to $8.50. This revision is due to a modest decrease in revenue growth outlook and a marginally higher discount rate.
Valuation Update With 7 Day Price Move • Nov 20Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to US$3.32, the stock trades at a trailing P/E ratio of 75.5x. Average forward P/E is 10x in the Insurance industry in the US. Total returns to shareholders of 11% over the past three years.
공시 • Nov 12eHealth Advances its AI Strategy with Expanded Voice Agent CapabilitieseHealth announced the expanded use of Alice, its AI-powered voice agent. Alice has expanded beyond its initial use for shopping and initial enrollment telephone support and is now assisting with post-enrollment and general service calls from Medicare Advantage beneficiaries, helping to efficiently address and resolve common inquiries such as: Application status: Alice provides customers with general information on their application status as provided by the health plan. Soon, she will also be able to look up specific details and inform callers exactly where their application is with the health plan in the process. ID card inquiries: Alice informs customers when they generally can expect to receive their insurance ID cards and, if necessary, directs them to contact their health plan for further assistance. Billing questions: Alice provides customers with direct billing contact phone numbers for their respective health plan, making it easier for individuals to access assistance when billing support is required. Do Not Call requests: Alice can initiate steps to remove customers from eHealth's call list upon request, ensuring their communication preferences are respected. eHealth's leadership in technology has defined the company since its founding. Today, eHealth has distinguished itself from other Medicare brokers by deploying leading AI technology at scale, continuing its commitment to improving the customer experience. The expansion of Alice marks another step forward in eHealth's mission to use technology to make healthcare simpler and more accessible for everyone. Alice already handles all after-hours Medicare Advantage inquiries and supports both initial enrollment assistance and service calls during business hours when agents are unavailable. In the future, eHealth plans to extend Alice's capabilities to assist individuals with shopping for other types of health insurance plans. For years, eHealth has leveraged AI and machine learning to match beneficiaries with the most suitable health plans based on their unique needs, including coverage requirements, physicians, and prescription drugs, from a broad catalog of leading national and regional insurers. To experience Alice in action, listen to this demo.
내러티브 업데이트 • Nov 12EHTH: Future Profit Margins Will Drive Upside Despite Consumer ConfusionAnalysts have revised their price target for eHealth down from $9.25 to $8.75. They cite a significant reduction in projected profit margin, even though revenue growth forecasts have slightly improved and the estimated future price-to-earnings ratio is notably higher.
Price Target Changed • Nov 12Price target decreased by 7.9% to US$8.75Down from US$9.50, the current price target is an average from 4 analysts. New target price is 111% above last closing price of US$4.14. Stock is down 22% over the past year. The company is forecast to post a net loss per share of US$0.90 next year compared to a net loss per share of US$1.19 last year.
Seeking Alpha • Nov 08eHealth: Undervalued And Gaining Momentum After Q3 Earnings BeatSummary eHealth Inc. is positioned for a turnaround, leveraging digital platform enhancements, cost optimization, and strong insurer partnerships. EHTH trades at a deep discount to peers despite improved financials, nearly debt-free balance sheet, and superior liquidity and margins. Key risks include seasonality, regulatory changes, and competition, but Q3 earnings and open enrollment are positive signs of a turnaround. We rate EHTH a BUY, expecting a rebound to tangible book value ($14-$18/share) if FY25 guidance is met or exceeded. Read the full article on Seeking Alpha
Reported Earnings • Nov 06Third quarter 2025 earnings: EPS and revenues exceed analyst expectationsThird quarter 2025 results: US$1.46 loss per share (improved from US$1.83 loss in 3Q 2024). Revenue: US$53.9m (down 7.8% from 3Q 2024). Net loss: US$44.6m (loss narrowed 17% from 3Q 2024). Revenue exceeded analyst estimates by 3.4%. Earnings per share (EPS) also surpassed analyst estimates by 19%. Revenue is forecast to grow 4.6% p.a. on average during the next 3 years, compared to a 5.1% growth forecast for the Insurance industry in the US. Over the last 3 years on average, earnings per share has increased by 68% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings.
공시 • Oct 31eHealth, Inc. to Report Q3, 2025 Results on Nov 05, 2025eHealth, Inc. announced that they will report Q3, 2025 results on Nov 05, 2025
분석 기사 • Oct 28eHealth, Inc. (NASDAQ:EHTH) Held Back By Insufficient Growth Even After Shares Climb 34%Despite an already strong run, eHealth, Inc. ( NASDAQ:EHTH ) shares have been powering on, with a gain of 34% in the...
공시 • Oct 01eHealth, Inc. Releases Findings from New SurveyeHealth, Inc. released findings from a new survey showing most Medicare beneficiaries find it confusing to shop for a plan during the Annual Enrollment Period (AEP), with about one-third of Medicare Advantage enrollees largely unaware of significant changes expected for the coming year. The survey of more than 1,500 Medicare beneficiaries offers timely insights as millions of Americans will soon make coverage decisions during this year's AEP, which runs from Oct. 15 through Dec. 7, 2025. Key findings from eHealth's survey include: 75% of Medicare beneficiaries said choosing a Medicare plan is confusing. 51% of Medicare beneficiaries intend to review their coverage options this AEP, compared to 63% who said they did so last year. 36% of Medicare Advantage and Part D plan enrollees said they are unaware that significant cost and benefit changes are expected for 2026. 33% of Medicare beneficiaries agree they don't have a good understanding of how Medicare Advantage, Medicare Supplement, and Part D plans differ. 33% of Medicare beneficiaries incorrectly believe Medicare covers GLP-1 drugs for weight loss. 29% of Medicare beneficiaries are unaware that Medicare covers recommended vaccines with no out-of-pocket costs.
공시 • Sep 20eHealth, Inc Announces Board and Committee ChangesOn September 17, 2025, Aaron Tolson notified the Board of Directors of eHealth, Inc. he is resigning from the Board, as well as from the Board’s compensation committee, nominating and corporate governance committee and government and regulatory affairs committee, effective immediately. Mr. Tolson was initially appointed to the Board as a designee of Echelon Health SPV, LP pursuant to the terms of the Investment Agreement, dated February 17, 2021, by and between the Company and H.I.G. The resignation of Mr. Tolson was not the result of any disagreement between Mr. Tolson and the Company. On September 17, 2025, the Board appointed Todd Arden as a member of the Board, effective immediately. Mr. Arden was appointed to the Board as a designee of H.I.G. pursuant to the Investment Agreement and to fill the vacancy created by Mr. Tolson’s resignation. Mr. Arden will serve as a Class I director, with a term expiring at the Company’s 2028 annual meeting of stockholders. Mr. Arden was also appointed to the Board’s Compensation Committee, Nominating Committee and Government and Regulatory Affairs Committee. On September 18, 2025, the Board increased the number of directors of the Company from nine to ten and appointed Derrick Duke to serve as a Class I director of the Board, effective immediately, with a term expiring at the Company’s 2028 annual meeting of stockholders. No arrangement or understanding exists between Derrick Duke and any other person pursuant to which he was appointed as a director.
분석 기사 • Sep 03eHealth, Inc. (NASDAQ:EHTH) Surges 26% Yet Its Low P/S Is No Reason For ExcitementThose holding eHealth, Inc. ( NASDAQ:EHTH ) shares would be relieved that the share price has rebounded 26% in the last...
Price Target Changed • Aug 26Price target decreased by 7.5% to US$9.25Down from US$10.00, the current price target is an average from 4 analysts. New target price is 141% above last closing price of US$3.84. Stock is down 5.4% over the past year. The company is forecast to post a net loss per share of US$0.84 next year compared to a net loss per share of US$1.19 last year.
분석 기사 • Aug 09The eHealth, Inc. (NASDAQ:EHTH) Second-Quarter Results Are Out And Analysts Have Published New ForecastsNasdaqGS:EHTH 1 Year Share Price vs Fair Value Explore eHealth's Fair Values from the Community and select yours...
Price Target Changed • Aug 07Price target decreased by 11% to US$9.50Down from US$10.63, the current price target is an average from 4 analysts. New target price is 158% above last closing price of US$3.68. Stock is down 9.6% over the past year. The company is forecast to post a net loss per share of US$1.02 next year compared to a net loss per share of US$1.19 last year.
Reported Earnings • Aug 06Second quarter 2025 earnings: EPS and revenues exceed analyst expectationsSecond quarter 2025 results: US$0.98 loss per share (improved from US$1.33 loss in 2Q 2024). Revenue: US$60.8m (down 7.7% from 2Q 2024). Net loss: US$29.8m (loss narrowed 24% from 2Q 2024). Revenue exceeded analyst estimates by 32%. Earnings per share (EPS) also surpassed analyst estimates by 33%. Revenue is forecast to grow 3.7% p.a. on average during the next 3 years, compared to a 5.4% growth forecast for the Insurance industry in the US. Over the last 3 years on average, earnings per share has increased by 62% per year but the company’s share price has fallen by 15% per year, which means it is significantly lagging earnings.
New Risk • Aug 03New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: US$97.3m This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (US$17m net loss in 2 years). Share price has been volatile over the past 3 months (11% average weekly change). Market cap is less than US$100m (US$97.3m market cap).
공시 • Jul 29eHealth, Inc. Announces CEO ChangeseHealth, Inc. announced that the Company's Board of Directors has appointed Derrick Duke as its next Chief Executive Officer. Duke will join eHealth on August 4, 2025, to begin the transition process before officially stepping into the CEO role and joining the Board of Directors on September 18th, 2025. He will succeed Fran Soistman, who, as previously announced, will retire from his role as CEO while continuing to serve on the Board. Soistman will remain with the Company as an executive advisor through December 31, 2025, to assist with the transition. Derrick Duke currently serves as CEO of Magellan Health, a leading national healthcare management organization and subsidiary of Centene Corporation. Previously, he held senior leadership roles at Magellan, including the dual roles of Chief Operating and Chief Financial Officer where he led the finance organization, business transformation initiatives, and behavioral health clinical services. Derrick Duke brings over 30 years of strategic leadership and financial expertise in the health insurance and managed care sectors. Most recently, he served as Chief Executive Officer at Magellan Health, a leading national healthcare management firm, where he led strategic growth and operational execution following a rapid rise through the C-suite – first as Chief Risk Officer in 2020, and then as Chief Operating and Financial Officer in early 2022.Before joining Magellan, Derrick spent nearly 16 years at Health Markets, one of the largest U.S. health insurance agencies, holding multiple senior roles including Chief Investment Officer, Chief Financial Officer, and Chief Operating Officer. He steered the company's finance, actuarial, IT, underwriting, compliance and customer service teams and helped lead the organization through its acquisition by UnitedHealth Group in 2019. Earlier in his career, Derrick was Executive Vice President and Chief Investment Officer at National Health Insurance (now part of Allstate Insurance), where he gained deep experience in investment strategy and insurer financial management. Derrick holds a bachelor's degree in finance from Hardin-Simmons University and an MBA from the University of Texas at Arlington.
공시 • Jul 24eHealth, Inc. to Report Q2, 2025 Results on Aug 06, 2025eHealth, Inc. announced that they will report Q2, 2025 results on Aug 06, 2025
분석 기사 • May 15eHealth, Inc.'s (NASDAQ:EHTH) 26% Dip In Price Shows Sentiment Is Matching RevenuesUnfortunately for some shareholders, the eHealth, Inc. ( NASDAQ:EHTH ) share price has dived 26% in the last thirty...
Major Estimate Revision • May 14Consensus EPS estimates upgraded to US$1.27 lossThe consensus outlook for fiscal year 2025 has been updated. 2025 losses forecast to reduce from -US$1.56 to -US$1.27 per share. Revenue forecast steady at US$531.4m. Insurance industry in the US expected to see average net income growth of 12% next year. Consensus price target down from US$10.63 to US$10.00. Share price fell 21% to US$4.53 over the past week.
New Risk • May 12New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of American stocks, typically moving 12% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (US$11m net loss in 2 years). Share price has been volatile over the past 3 months (12% average weekly change).
Reported Earnings • May 08First quarter 2025 earnings: EPS and revenues exceed analyst expectationsFirst quarter 2025 results: EPS: US$0.077 (up from US$0.96 loss in 1Q 2024). Revenue: US$113.1m (up 22% from 1Q 2024). Net income: US$2.31m (up US$30.0m from 1Q 2024). Profit margin: 2.0% (up from net loss in 1Q 2024). The move to profitability was primarily driven by higher revenue. Revenue exceeded analyst estimates by 14%. Earnings per share (EPS) also surpassed analyst estimates. Revenue is forecast to grow 3.0% p.a. on average during the next 3 years, compared to a 5.1% growth forecast for the Insurance industry in the US. Over the last 3 years on average, earnings per share has increased by 53% per year but the company’s share price has fallen by 18% per year, which means it is significantly lagging earnings.
공시 • Apr 30eHealth, Inc. Introduces AI Voice Agents to Enhance Customer Experience in Health Plan SelectioneHealth, Inc. unveiled a new AI-based voice, non-licensed agent designed to streamline the health insurance plan selection process. This launch marks a significant milestone in eHealth's ongoing, multi-year strategy to leverage AI empathetically, enhancing the expertise of licensed insurance agents to provide an exceptional consumer experience. The AI-based voice agents started by handling incoming Medicare calls to eHealth during after-hours, reducing the wait time for consumers who may otherwise need to wait longer to speak with a human screener. The AI-powered voice agents can enhance the customer experience by initiating the customer intake process, gathering personal information, checking initial eligibility, and communicating necessary disclosures. Since launching as a pilot earlier in 2025, among callers served by the AI agents, the program has: Eliminated after-hours wait times and ensured a 100% answer rate. Nearly doubled the percentage of callers (18.5% compared to 34.5%) who expressed interest in purchasing a plan, as compared to human screeners. The AI-based agents have expanded from initially handling after-hours calls to now assisting with incoming Medicare calls during business hours on a pilot basis. In the future, the AI agents are expected to serve people calling eHealth shopping for other types of insurance plans. In addition, a recent eHealth survey of over 500 consumers found significant interest in the use of AI to improve the experience when calling customer service. Among the findings from the survey regarding customer service in general: 74% are willing to answer a few questions from an AI assistant if it means getting faster and better help later in the process. 56% agree that working with an AI assistant can provide them with faster, more accurate help. 66% said long hold times are the biggest frustration when calling customer service, followed by difficulty reaching a real person (59%) and poorly trained agents (42%). Key features of the new eHealth AI-based voice agents: Streamlined information gathering. Using a conversational approach, the AI-based voice agents gather key details, including personal information, initial eligibility, and plan preferences. By streamlining the process, the AI agents can eliminate wait times and reduce the effort required for callers to shop for health benefits, making the plan selection process more accessible for everyone. Enhanced accuracy and cost efficiency. Using advanced algorithms and voice-recognition technology, the AI agents help minimize errors and ensure callers are matched with an appropriate licensed insurance agent to then review appropriate plan options based on location, health care goals and budget. Compared to human screeners, the AI agents are more cost efficient. User-friendly and consistent service: The intuitive experience of the AI-based voice agents enables users to provide initial information more easily and start the plan selection experience, while expediting the process once the caller is connected to a live, licensed insurance agent. The AI agents are designed to answer all customer questions with empathy and patience, with feedback from callers emphasizing feelings of being respected and valued.
공시 • Apr 29eHealth, Inc., Annual General Meeting, Jun 18, 2025eHealth, Inc., Annual General Meeting, Jun 18, 2025.
공시 • Apr 24eHealth, Inc. to Report Q1, 2025 Results on May 07, 2025eHealth, Inc. announced that they will report Q1, 2025 results at 12:30 PM, US Eastern Standard Time on May 07, 2025
새로운 내러티브 • Mar 31Medicare Focus And AI Projects Will Improve Operations Revenue and earnings growth driven by increased Medicare submissions, marketing investments, and enhanced enrollment margins.
분석 기사 • Mar 16Benign Growth For eHealth, Inc. (NASDAQ:EHTH) Underpins Stock's 30% PlummetThe eHealth, Inc. ( NASDAQ:EHTH ) share price has softened a substantial 30% over the previous 30 days, handing back...
Major Estimate Revision • Mar 06Consensus EPS estimates fall by 39%The consensus outlook for fiscal year 2025 has been updated. 2025 expected loss increased from -US$1.12 to -US$1.56 per share. Revenue forecast unchanged at US$529.8m. Insurance industry in the US expected to see average net income growth of 8.4% next year. Consensus price target up from US$8.63 to US$10.63. Share price fell 6.7% to US$8.29 over the past week.
Breakeven Date Change • Mar 02No longer forecast to breakevenThe 5 analysts covering eHealth no longer expect the company to break even during the foreseeable future. The company was expected to make a profit of US$2.28m in 2026. New consensus forecast suggests the company will make a loss of US$16.6m in 2026.
공시 • Mar 01Ehealth, Inc. Provides Earnings Guidance for the Full Year Ending December 31, 2025eHealth, Inc. provided earnings guidance for the full year ending December 31, 2025. For the year, the company expects Total revenue is expected to be in the range of $510.0 million to $550.0 million. GAAP net income (loss) is expected to be in the range of $(10.0) million to $15.0 million.
Reported Earnings • Feb 26Full year 2024 earnings: EPS and revenues exceed analyst expectationsFull year 2024 results: US$1.19 loss per share (improved from US$2.37 loss in FY 2023). Revenue: US$532.4m (up 18% from FY 2023). Net loss: US$35.0m (loss narrowed 47% from FY 2023). Revenue exceeded analyst estimates by 4.3%. Earnings per share (EPS) also surpassed analyst estimates by 15%. Revenue is forecast to grow 4.0% p.a. on average during the next 2 years, compared to a 5.2% growth forecast for the Insurance industry in the US. Over the last 3 years on average, earnings per share has increased by 40% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings.
Seeking Alpha • Feb 26eHealth: Another Big Run, Lock In, And Run House MoneySummary eHealth, Inc. was recommended at $6.78; now, with current gains to above $9, we suggest you lock in profits and hold EHTH stock for long-term growth. eHealth showed strong Q4 performance, but it was an outlier. We like EHTH shares for long-term exposure, but 2025 at best looks flat from 2024. Consider a house position after the rapid-return trade. Read the full article on Seeking Alpha
공시 • Feb 13eHealth, Inc. to Report Q4, 2024 Results on Feb 26, 2025eHealth, Inc. announced that they will report Q4, 2024 results on Feb 26, 2025
공시 • Jan 29"Iris by eHealth" ICHRA Solution Makes Employer Health Benefits Affordable with Personalized Coverage for EmployeeseHealth, Inc. announced the launch of Iris by eHealth, an end-to-end Individual Coverage Health Reimbursement Account (ICHRA) solution for employers who want to support employee healthcare but struggle with the unpredictable costs of group health plans. Here's how Iris by eHealth works: The employer determines a flat monthly contribution to be made toward each employee's health coverage, Using eHealth's Iris platform, employees select their own plan from among top insurance companies in their area, By adding their preferred doctors and prescriptions, they can narrow down their choices to those best suited to their personal needs, eHealth's proven customer care team manages enrollments and provides direct support to employees, Once enrolled, the employer's monthly contribution funds some, or all, of the employee's health insurance premiums. There are no plan markups or hidden fees with Iris. eHealth's licensed agents are available nationwide by phone or chat to help employers and their employees find the coverage they need, with a free annual review of plan options.
Major Estimate Revision • Jan 12Consensus EPS estimates fall by 23%, revenue upgradedThe consensus outlook for fiscal year 2024 has been updated. 2024 revenue forecast increased from US$498.0m to US$504.0m. Forecast EPS reduced from -US$1.14 to -US$1.40 per share. Insurance industry in the US expected to see average net income growth of 13% next year. Consensus price target up from US$7.38 to US$8.63. Share price rose 3.1% to US$9.85 over the past week.
Breakeven Date Change • Dec 31Forecast to breakeven in 2026The 5 analysts covering eHealth expect the company to break even for the first time. New consensus forecast suggests losses will reduce by 25% per year to 2025. The company is expected to make a profit of US$2.28m in 2026. Average annual earnings growth of 79% is required to achieve expected profit on schedule.
분석 기사 • Dec 23Market Might Still Lack Some Conviction On eHealth, Inc. (NASDAQ:EHTH) Even After 66% Share Price BoosteHealth, Inc. ( NASDAQ:EHTH ) shares have continued their recent momentum with a 66% gain in the last month alone. Not...
Price Target Changed • Dec 19Price target increased by 11% to US$7.38Up from US$6.63, the current price target is an average from 4 analysts. New target price is 11% below last closing price of US$8.28. Stock is down 7.7% over the past year. The company is forecast to post a net loss per share of US$1.50 next year compared to a net loss per share of US$2.37 last year.
공시 • Dec 18eHealth, Inc. Revises Earnings Guidance for the Full Year Ending December 31, 2024eHealth, Inc. revised earnings guidance for the full year ending December 31, 2024. Total revenue is expected to be in the range of $500.0 million to $520.0 million compared to the prior range of $470.0 million to $495.0 million. GAAP net income (loss) is expected to be in the range of $(12.0) million to $3.0 million compared to the prior range of $(36.5) million to $(22.0) million.
New Risk • Dec 17New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of American stocks, typically moving 14% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (US$13m net loss in 2 years). Share price has been volatile over the past 3 months (14% average weekly change). Shareholders have been diluted in the past year (4.5% increase in shares outstanding). Significant insider selling over the past 3 months (US$105k sold).
Seeking Alpha • Dec 17Bull Run For EHealth, Inc.: Stock Flying On Solid EnrollmentSummary eHealth, Inc. is an online health insurance marketplace with strong enrollment, particularly in Medicare plans, aided by new technologies and live assistance. Despite a 90%+ drop from its 2020 peak, Q3 2024 showed signs of improvement, with a 16% decline in acquisition costs and a 6% reduction in adjusted net loss. Significant growth in submitted Medicare applications and a new member retention program have led to raised revenue and profit guidance for 2024. EHTH stock, is likely heading to double digits in 2025, driven by improved outlook and retention strategies. Read the full article on Seeking Alpha
Board Change • Dec 01Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 8 experienced directors. No highly experienced directors. Independent Director Prama Bhatt was the last director to join the board, commencing their role in 2024. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Price Target Changed • Nov 26Price target decreased by 8.7% to US$7.00Down from US$7.67, the current price target is an average from 3 analysts. New target price is 30% above last closing price of US$5.37. Stock is down 28% over the past year. The company is forecast to post a net loss per share of US$1.54 next year compared to a net loss per share of US$2.37 last year.
Recent Insider Transactions • Nov 15Independent Director recently sold US$105k worth of stockOn the 11th of November, Dale Wolf sold around 20k shares on-market at roughly US$5.25 per share. This transaction amounted to 14% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Despite this recent sale, insiders have collectively bought US$253k more than they sold in the last 12 months.
Recent Insider Transactions Derivative • Nov 11Independent Director notifies of intention to sell stockDale Wolf intends to sell 20k shares in the next 90 days after lodging an Intent To Sell Form on the 8th of November. If the sale is conducted around the recent share price of US$5.43, it would amount to US$109k. Since June 2024, Dale has owned 139.73k shares directly. Company insiders have collectively bought US$358k more than they sold, via options and on-market transactions, in the last 12 months.
분석 기사 • Nov 08A Piece Of The Puzzle Missing From eHealth, Inc.'s (NASDAQ:EHTH) 31% Share Price ClimbThe eHealth, Inc. ( NASDAQ:EHTH ) share price has done very well over the last month, posting an excellent gain of 31...
Reported Earnings • Nov 07Third quarter 2024 earnings: EPS misses analyst expectationsThird quarter 2024 results: US$1.83 loss per share (further deteriorated from US$1.68 loss in 3Q 2023). Revenue: US$58.4m (down 9.7% from 3Q 2023). Net loss: US$53.9m (loss widened 14% from 3Q 2023). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 20%. Revenue is forecast to grow 8.3% p.a. on average during the next 3 years, compared to a 5.2% growth forecast for the Insurance industry in the US. Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has fallen by 43% per year, which means it is significantly lagging earnings.
공시 • Oct 23eHealth, Inc. to Report Q3, 2024 Results on Nov 06, 2024eHealth, Inc. announced that they will report Q3, 2024 results on Nov 06, 2024
Board Change • Sep 01Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 7 experienced directors. No highly experienced directors. CEO & Director Fran Soistman was the last director to join the board, commencing their role in 2021. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
분석 기사 • Aug 30Positive Sentiment Still Eludes eHealth, Inc. (NASDAQ:EHTH) Following 25% Share Price SlumpTo the annoyance of some shareholders, eHealth, Inc. ( NASDAQ:EHTH ) shares are down a considerable 25% in the last...
Price Target Changed • Aug 14Price target decreased by 17% to US$6.67Down from US$8.00, the current price target is an average from 3 analysts. New target price is 65% above last closing price of US$4.04. Stock is down 52% over the past year. The company is forecast to post a net loss per share of US$1.52 next year compared to a net loss per share of US$2.37 last year.
Major Estimate Revision • Aug 14Consensus EPS estimates fall by 99%, revenue upgradedThe consensus outlook for fiscal year 2024 has been updated. 2024 revenue forecast increased from US$468.5m to US$481.6m. Forecast EPS reduced from -US$0.76 to -US$1.52 per share. Insurance industry in the US expected to see average net income growth of 16% next year. Consensus price target down from US$8.00 to US$6.67. Share price rose 5.5% to US$4.04 over the past week.
New Risk • Aug 11New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of American stocks, typically moving 10.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Currently unprofitable and not forecast to become profitable over next 2 years (US$15m net loss in 2 years). Share price has been volatile over the past 3 months (10.0% average weekly change). Shareholders have been diluted in the past year (4.7% increase in shares outstanding).
Price Target Changed • Aug 08Price target decreased by 8.0% to US$7.67Down from US$8.33, the current price target is an average from 3 analysts. New target price is 88% above last closing price of US$4.07. Stock is down 54% over the past year. The company is forecast to post a net loss per share of US$0.88 next year compared to a net loss per share of US$2.37 last year.
공시 • Aug 07eHealth, Inc. Announces Retirement of Fran Soistman as Chief Executive OfficereHealth, Inc. announced that Fran Soistman will retire from his role as Chief Executive Officer upon the appointment of a successor, which is expected to occur by or before the second quarter of 2025. Following his retirement as CEO, Mr. Soistman intends to remain a director on the Company's Board of Directors. Mr. Soistman will support the new CEO to ensure a seamless transition. The Board has commenced a search for Mr. Soistman's successor and has engaged Spencer Stuart, to identify and evaluate both internal and external candidates.
공시 • Jul 23eHealth, Inc. to Report Q2, 2024 Results on Aug 07, 2024eHealth, Inc. announced that they will report Q2, 2024 results on Aug 07, 2024
공시 • Jul 03+ 4 more updateseHealth, Inc.(NasdaqGS:EHTH) dropped from Russell 3000 IndexeHealth, Inc.(NasdaqGS:EHTH) dropped from Russell 3000 Index
